Excitotoxicity in ALS: Overstimulation, or overreaction?

被引:122
|
作者
King, Anna E. [1 ]
Woodhouse, Adele [1 ]
Kirkcaldie, Matthew T. K. [1 ]
Vickers, James C. [1 ]
机构
[1] Univ Tasmania, Fac Hlth, Wicking Dementia Res & Educ Ctr, Hobart, Tas 7000, Australia
基金
英国医学研究理事会;
关键词
ALS; Motor neuron disease; Glutamate; GABA; Glycine; Interneuron; EAAT2; Excitability; AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; TRANSGENIC MOUSE MODEL; AXONAL EXCITABILITY PROPERTIES; GLUTAMATE TRANSPORTER PROTEIN; THRESHOLD TRACKING TECHNIQUES; STRENGTH-DURATION PROPERTIES; ACTIVITY-DEPENDENT CHANGES; PERMEABLE AMPA RECEPTORS; PERSISTENT NA+ CURRENTS;
D O I
10.1016/j.expneurol.2015.09.019
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Amyotrophic lateral sclerosis (ALS) is an adult onset neurodegenerative disease that results in motor dysfunction and death, generally from respiratory failure. 90% of ALS cases are sporadic with no known cause. Familial cases have been linked with mutations in several disparate classes of genes, including those involved in DNA/RNA metabolism, protein misfolding, oxidative stress and the cytoskeleton, leading to the proposition that ALS could be a multi-factorial disease. However, alterations in excitability have been reported in all types of ALS cases, and may be a common disease mechanism predisposing neurons to degeneration. Excitotoxicity has long been suspected as a mediator in the disease process, and may arise from changes in synaptic inputs, or alterations in the excitability of the neurons being stimulated. Although the glutamatergic system is widely recognised as a therapeutic avenue with the potential to extend lifespan and delay disease onset, the causes of altered excitability in ALS are currently unclear and warrant further investigation. This article reviews current evidence of alterations to excitatory and inhibitory signalling in the cortex and spinal cord, and in the intrinsic excitability of motor neurons, in ALS. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:162 / 171
页数:10
相关论文
共 50 条
  • [1] Excitotoxicity in ALS
    Leigh, PN
    Meldrum, BS
    [J]. NEUROLOGY, 1996, 47 (06) : S221 - S227
  • [2] The role of excitotoxicity in ALS - what is the evidence?
    Ludolph, AC
    Meyer, T
    Riepe, MW
    [J]. JOURNAL OF NEUROLOGY, 2000, 247 : 7 - 16
  • [3] The role of excitotoxicity in ALS – what is the evidence?
    A. C. Ludolph
    T. Meyer
    M. W. Riepe
    [J]. Journal of Neurology, 2000, 247 (Suppl 1) : I7 - I16
  • [4] Excitotoxicity, old but new vistas to ALS therapy
    Kwak, Shin
    [J]. NEUROSCIENCE RESEARCH, 2009, 65 : S29 - S29
  • [5] NMDA receptor overstimulation triggers a prolonged wave of immediate early gene expression: Relationship to excitotoxicity
    Shan, Y
    Carlock, LR
    Walker, PD
    [J]. EXPERIMENTAL NEUROLOGY, 1997, 144 (02) : 406 - 415
  • [6] Evidence for an excitotoxicity in murine model of ALS-PDC
    Wilson, JM
    Shaw, CA
    [J]. JOURNAL OF NEUROCHEMISTRY, 2006, 96 : 87 - 87
  • [7] Excitotoxicity and ALS : New therapy targets an old mechanism
    Smith, Hannah Louise
    Chaytow, Helena
    Gillingwater, Thomas Henry
    [J]. CELL REPORTS MEDICINE, 2024, 5 (02)
  • [8] Overreaction
    Dreman, D
    [J]. FORBES, 1999, 164 (08): : 146 - 146
  • [9] Overreaction?
    Ellis, S
    [J]. NEW SCIENTIST, 2002, 173 (2334) : 58 - 58
  • [10] Overreaction
    Shell, Ellen Ruppel
    [J]. SCIENTIFIC AMERICAN, 2015, 313 (05) : 28 - 29